Literature DB >> 26086968

Report on the 5th International Workshop on Positron Emission Tomography in Lymphoma held in Menton, France, 19-20 September 2014.

Michel Meignan1, Andrea Gallamini, Corinne Haioun, Sally Barrington, Emmanuel Itti, Stefano Luminari, Aaron Polliack.   

Abstract

Two hundred and thirty-six nuclear medicine physicians, radiologists and hematologists from 28 countries attended the 5th International Workshop on Postron Emission Tomography (PET) in Lymphoma held in Menton, France in September 2014. Forty-five scientific posters were presented. Following Lugano recommendations, the aim of the 5th workshop was to implement PET/computed tomography (CT) interpretation in a quantitative way (Q-PET) and how to use the new proposed metrics such as metabolic tumor volume (MTV). These parameters, in turn, could be combined with clinical, biological and molecular markers to build new indices for better patient risk stratification and to guide personalized therapy. New imaging techniques such as PET/magnetic resonance imaging (MRI) and genomics related to tumor morphological and structural characteristics and PET for assessment of response to new drugs and targeted therapies was also addressed. Finally, a section dedicated to imaging of pediatric lymphoma was also introduced.

Entities:  

Keywords:  PET; consensus; international PET workshop; lymphoma

Mesh:

Year:  2015        PMID: 26086968     DOI: 10.3109/10428194.2015.1029748

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN: 1026-8022


  8 in total

1.  Dose-adjusted EPOCH regimen as first-line treatment for non-Hodgkin lymphoma-associated hemophagocytic lymphohistiocytosis: a single-arm, open-label, phase II trial.

Authors:  Jin-Hua Liang; Li Wang; Hua-Yuan Zhu; Jun Qian; Hui Liao; Jia-Zhu Wu; Yi Xia; Wei Wu; Lei Cao; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  Haematologica       Date:  2019-05-09       Impact factor: 9.941

2.  DA-EPOCH-R improves the outcome over that of R-CHOP regimen for DLBCL patients below 60 years, GCB phenotype, and those with high-risk IPI, but not for double expressor lymphoma.

Authors:  Xin-Yu Zhang; Jin-Hua Liang; Li Wang; Hua-Yuan Zhu; Wei Wu; Lei Cao; Lei Fan; Jian-Yong Li; Wei Xu
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-16       Impact factor: 4.553

3.  Positron Emission Tomography-Based Assessment of Metabolic Tumor Volume Predicts Survival after Autologous Hematopoietic Cell Transplantation for Hodgkin Lymphoma.

Authors:  Vít Procházka; Rakhee S Gawande; Zuzan Cayci; Jerry W Froelich; Qing Cao; Chris Wilke; Kathryn Dusenbery; Daniel J Weisdorf; Veronika Bachanova
Journal:  Biol Blood Marrow Transplant       Date:  2017-09-20       Impact factor: 5.742

4.  Interim FDG-PET in lymphoma, a questionable practice in hematology.

Authors:  Hugo J A Adams; Thomas C Kwee
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-07-31       Impact factor: 9.236

5.  Evolution of lymphoma staging and response evaluation: current limitations and future directions.

Authors:  Joel Cunningham; Sunil Iyengar; Bhupinder Sharma
Journal:  Nat Rev Clin Oncol       Date:  2017-06-13       Impact factor: 66.675

6.  18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.

Authors:  Chiara Giraudo; Markus Raderer; Georgios Karanikas; Michael Weber; Barbara Kiesewetter; Werner Dolak; Ingrid Simonitsch-Klupp; Marius E Mayerhoefer
Journal:  Invest Radiol       Date:  2016-03       Impact factor: 6.016

7.  Comparison of Three Chemotherapy Regimens in Elderly Patients with Diffuse Large B Cell Lymphoma: Experience at a Single National Reference Center in Mexico.

Authors:  Diana Nolasco-Medina; Nancy Reynoso-Noveron; Alejandro Mohar-Betancourt; Alejandro Aviles-Salas; Osvaldo García-Perez; Myrna Candelaria
Journal:  Biomed Res Int       Date:  2016-07-10       Impact factor: 3.411

8.  Assessment of alteration in liver 18F-FDG uptake due to steatosis in lymphoma patients and its impact on the Deauville score.

Authors:  Thibault Salomon; Catherine Nganoa; Anne-Claire Gac; Christophe Fruchart; Gandhi Damaj; Nicolas Aide; Charline Lasnon
Journal:  Eur J Nucl Med Mol Imaging       Date:  2017-12-26       Impact factor: 9.236

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.